Here are five key notes:
1. Credit Suisse gave Zimmer Biomet an “outperform” rating as the firm initiated coverage.
2. The share price target price is $107 per share.
3. Zimmer Biomet share price rose 1.06 percent on Friday and was one of the biggest gainers of the day. However, it has dropped 10.18 percent during the last three-month period.
4. The 52-week high share price is $121.84 and the 52-week low is $88.77.
5. Zimmer Biomet’s market cap is $19.6 billion.
More articles on orthopedic devices:
Global minimally invasive neurosurgery devices market on the rise: 5 things to know
Exactech, LDR, LifeSpine & more—21 key notes
DePuy Synthes Trauma develops new trauma biologic implant
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
